LL-37 / working resource

Product comparison desk

Compare the actual ingredient, route, formulation and source rather than treating a shared name as equivalence.

Start with the product-specific question

Cathelicidin and innate immunity

Antimicrobial mechanism separated from treatment claims. What should I know about cathelicidin and innate immunity?

The early randomized study enrolled 34 people and investigated topical LL37 for venous leg ulcers over a four-week treatment period.
Read the original record ↗

Open the LL-37 library ↗

Give each product its own record.

For LL-37, a similar label is only the start. Compare the exact ingredient and route before comparing outcomes or cost. A related molecule, a blend and a different delivery method belong in separate columns.

Product A

Product A: Exact product and ingredientProduct A: Formulation and routeProduct A: Strength as written on the labelProduct A: Source or dispensing organizationProduct A: Evidence for this exact formProduct A: Total cost and included supply

Product B

Product B: Exact product and ingredientProduct B: Formulation and routeProduct B: Strength as written on the labelProduct B: Source or dispensing organizationProduct B: Evidence for this exact formProduct B: Total cost and included supply

Explain the meaningful difference.

What should I know about cathelicidin and innate immunity?What should I know about antimicrobial test-tube findings versus infection treatment?What should I know about wound-healing studies and their populations?Which differences would change the decision, and why?

A completed table does not establish interchangeability. Ask the clinician or pharmacist to resolve any uncertainty before substituting products.

These fields stay in this page until you leave or reload. No notes are saved or transmitted. Print a copy if you want to keep your work. Educational organization tools do not replace clinical advice.

Explore all six resources ↗